Volume 26, Number 8—August 2020
Dispatch
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids
Table
Specimens | Mild cases, n = 43 |
Severe cases, n = 6 |
|||
---|---|---|---|---|---|
Median (95% CI) | 95th percentile (95% CI) | Median (95% CI) | 95th percentile (95% CI) | ||
Throat swab | 15.6 (11.8–20.7) | 32.8 (25.9–42.3) | 33.9 (24.2–47.3) | 53.9 (39.4–81.7) | |
Sputum | 20.0 (14.1–27.0) | 43.7 (33.6–60.4) | 30.9 (23.5–39.1) | 44.7 (36.3–58.0) | |
Nasopharyngeal swab | 22.7 (18.8–27.5) | 46.3 (39.0–55.2) | 33.5 (25.7–42.7) | 49.4 (38.4–68.5) | |
Feces | 24.5 (21.2–28.3) | 45.6 (40.0–52.8) | 32.5 (26.3–39.1) | 48.9 (41.3–59.7) |
*The time until the loss of SARS-CoV-2 RNA detection in each body fluid was estimated by using parametric Weibull regression models. Data are presented as medians and 95th percentiles in days after illness onset. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
1These authors contributed equally to this work.
Page created: May 08, 2020
Page updated: July 19, 2020
Page reviewed: July 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.